SCHEMBL21708690

SCHEMBL21708690

CCCC(F)OC(=O)CCC(C#N)c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 6/20 0.39
CYP1A2 P05177 2/20 0.36
CCR1 P32246 1/20 0.36
PDE4A P27815 2/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
KCNA5 P22460 2/20 0.34
KCNH2 Q12809 1/20 0.34
TSHR P16473 3/20 0.33
CYP2C19 P33261 2/20 0.33
KDM4E B2RXH2 4/20 0.33
MAPT P10636 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
CYP3A4 P08684 3/20 0.33
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708722 0.90 SMN1; SMN2 (0.48) SMN1; SMN2GAAMEN1KMT2AALDH1A1
SCHEMBL21708794 0.81 GAA (0.38) SMN1; SMN2GAAMEN1KMT2AALDH1A1
SCHEMBL21708707 0.79 CCR1 (0.36) MEN1KMT2AALDH1A1CCR1KDM4E
SCHEMBL21708548 0.79 MEN1 (0.35) SMN1; SMN2GAAMEN1KMT2AALDH1A1
SCHEMBL21656110 0.79 SMN1; SMN2 (0.48) SMN1; SMN2GAAMEN1KMT2AALDH1A1
SCHEMBL21708512 0.78 CCR1 (0.36) SMN1; SMN2GAAMEN1KMT2AALDH1A1
SCHEMBL21708544 0.78 POLB (0.38) MEN1KMT2ATSHRLMNAHPGD
SCHEMBL21708545 0.78 KMT2A (0.33) KMT2A
SCHEMBL21708518 0.77 TAS1R3 (0.32) MEN1KMT2AHSD17B10
SCHEMBL21632100 0.76 SMN1; SMN2 (0.49) SMN1; SMN2GAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed